Actively Recruiting

Age: 18Years +
All Genders
NCT06462742

Microwave Ablation Versus Liver Resection for Intrahepatic Cholangiocarcinoma

Led by Chinese PLA General Hospital · Updated on 2024-07-25

1000

Participants Needed

1

Research Sites

1065 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Thermal ablation has been recommended by worldwide guidelines as first-line treatment for hepatocellular carcinoma (HCC), while evidence regarding its efficacy for primary intrahepatic cholangiocarcinoma (iCCA) is lacking. The goal of this observational study is to study the efficacy of ablation in treating iCCA by comparing its prognosis with surgery. The main questions it aims to answer are: * Whether microwave ablation could achieve similar efficacy with liver resection in treating iCCA * What is the risk factor for ablation or surgery in treating iCCA * What kind of iCCA patients could receive ablation as their first-line treatment In this real-world multicenter cohort study, we will collect data of iCCA patients from hospitals who underwent microwave ablation (MWA) or liver resection (LR) for tumors within Milan criteria. Survival will be compared between patients treated by MWA or LR.

CONDITIONS

Official Title

Microwave Ablation Versus Liver Resection for Intrahepatic Cholangiocarcinoma

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Pathologically diagnosed intrahepatic cholangiocarcinoma (iCCA) based on WHO classifications
  • Curative-intent treatment with liver resection or microwave ablation
  • Tumor within Milan criteria: single tumor 5 cm or less; up to 3 tumors each 3 cm or less; no major vascular or hilar invasion; no extrahepatic or lymphatic metastasis or other malignancies
  • Age 18 years or older
Not Eligible

You will not qualify if you...

  • Not meeting any one of the inclusion criteria

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Chinese PLA General Hospital

Beijing, Beijing Municipality, China, 100853

Actively Recruiting

Loading map...

Research Team

C

Chuan Pang, Doctor

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here